Patents Examined by Irene Marx
  • Patent number: 10334855
    Abstract: Methods for improving the ability of a population of biological agents to compete and survive in a field setting are provided. The improved, modified population of agents is able to grow, compete with other microbial strains and fungi, and provide protection for plants from pathogens. Modified biological agents and modified populations of such agents that are herbicide tolerant or resistant are selected or engineered. In this manner, the protection from disease-causing agents is enhanced. Such modified populations can be added to soils to prevent fungal pathogens and the associated diseases thereby promoting plant growth. The present invention is useful for enhancing the competitiveness of modified biological agents particularly over other microbial agents which are not herbicide resistant. Disclosed compositions include selected or engineered herbicide resistant biological agents and modified populations of biocontrol agents.
    Type: Grant
    Filed: September 27, 2018
    Date of Patent: July 2, 2019
    Assignee: AGBIOME, INC.
    Inventors: Philip E. Hammer, Janice C. Jones, Michael G. Koziel, Scott Joseph Uknes
  • Patent number: 10307445
    Abstract: The invention relates to bacterial strains having an outstanding ability to produce menaquinone and to applications thereof.
    Type: Grant
    Filed: September 21, 2015
    Date of Patent: June 4, 2019
    Assignee: DuPont Nutrition Bioscience ApS
    Inventors: Pascal Fourcassie, Patrick Boyaval, Philippe Horvath
  • Patent number: 10301589
    Abstract: The present invention relates generally to microalgae strains that are tolerant to high salinity, the products derived from the high salinity tolerant microalgae strains, and methods of producing high salinity tolerant microalgae strains and their products.
    Type: Grant
    Filed: September 19, 2016
    Date of Patent: May 28, 2019
    Assignee: Khalifa University of Science and Technology
    Inventors: Ahmed Husain Al Harethi, Hector Hugo Hernandez
  • Patent number: 10301690
    Abstract: Provided are a novel streptomyces filamentosus strain with improved daptomycin productivity, and a method for producing daptomycin using the same.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: May 28, 2019
    Assignee: DONG KOOK PHARM CO., LTD.
    Inventors: Kang Hee Lee, Kye Wan Lee, Kyung Hoi Cha
  • Patent number: 10286020
    Abstract: The present invention relates to a novel bacteriophage ?CJ24 (KCCM11462P) and a composition comprising the same as an active component. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic E. coli of birds by using the bacteriophage ?CJ24 (KCCM11462P) or the composition.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: May 14, 2019
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Patent number: 10285933
    Abstract: A personal care composition includes an ozone-stressed yeast lysate; and a preservative, in which the preservative is selected from phenoxyethanol, isopropyl alcohol, benzyl alcohol, propylene glycol, butylene glycol, pentylene glycol, methylparaben, propylparaben, butylparaben, benzalkonium chloride, Quaternium 15, methylisothiazolinone, methylchloroisothiazolinone, DMDM hydantoin, imidazolidinyl urea, diazolidinyl urea, butylated hydroxytoluene, tocopherol, triclosan, chlorohexidine digluconate, and combinations thereof, and the ozone-stressed yeast lysate is produced by a method including exposing growing yeast to ozone by aerating the yeast for a time period of between five minutes and seventy-two hours with an aeration gas having an ozone concentration of from 0.0001 millimolar (mM) to 1.
    Type: Grant
    Filed: August 12, 2016
    Date of Patent: May 14, 2019
    Assignee: ARCH PERSONAL CARE PRODUCTS L.P.
    Inventor: James Vincent Gruber
  • Patent number: 10278397
    Abstract: Methods for improving the ability of a population of biological agents to compete and survive in a field setting are provided. The improved, modified population of agents is able to grow, compete with other microbial strains and fungi, and provide protection for plants from pathogens. Modified biological agents and modified populations of such agents that are herbicide tolerant or resistant are selected or engineered. In this manner, the protection from disease-causing agents is enhanced. Such modified populations can be added to soils to prevent fungal pathogens and the associated diseases thereby promoting plant growth. The present invention is useful for enhancing the competitiveness of modified biological agents particularly over other microbial agents which are not herbicide resistant. Disclosed compositions include selected or engineered herbicide resistant biological agents and modified populations of biocontrol agents.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: May 7, 2019
    Assignee: AGBIOME, INC.
    Inventors: Philip E. Hammer, Janice C. Jones, Michael G. Koziel, Scott Joseph Uknes
  • Patent number: 10278396
    Abstract: The present invention generally relates to the use of synergistic amounts of Bacillus thuringiensis subsp. kurstaki and cyantraniliprole for the control of diamondback moths, Beet armyworm, sugarcane borer, and Soybean looper. Specifically, the synergistic weight ratio of Bacillus thuringiensis subsp. kurstaki to cyantraniliprole is from about 1:0.0025 to about 1:15.
    Type: Grant
    Filed: April 27, 2017
    Date of Patent: May 7, 2019
    Assignee: VALENT BIOSCIENCES LLC
    Inventors: Deanna D. Branscome, Roger D. Storey, James Russell Eldridge, Emily E. Brazil
  • Patent number: 10273513
    Abstract: A method for producing bacterial cellulose, said method comprising culturing a biologically pure culture of a cellulose-producing Proteus strain in a liquid medium suitable for culturing facultatively anaerobic microorganisms, separating bacterial cellulose produced in said liquid medium from said liquid medium, washing said separated bacterial cellulose and drying said bacterial cellulose. The cellulose-producing Proteus strain is preferably a Proteus myxofaciens strain, preferably strain IDAC 071005-01 or strain ATCC 19692. The liquid medium is provided with a carbohydrate substrate containing at least one sugar selected from the group consisting of glucose, sucrose, fructose, lactose, xylose, and rhamnose. A bacterial cellulose product produced by culturing a biologically pure culture of a cellulose-producing Proteus strain in a liquid medium suitable for culturing facultatively anaerobic microorganisms.
    Type: Grant
    Filed: September 15, 2016
    Date of Patent: April 30, 2019
    Assignee: Her Majesty The Queen in Right of Canada as represented by the Minister of Agriculture and Agri-Food Canada
    Inventor: Pascal Delaquis
  • Patent number: 10251920
    Abstract: The invention relates to new isolated Lactobacillus and Bifidobacterium strains which have been isolated from fresh honey having a water content above 18% by weight or from the honey producing tract of at least one bee. The bacterial strains have unique properties rendering them useful in many products such as in food and beverage products, feed products, and medica products.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: April 9, 2019
    Inventors: Tobias Olofsson, Alejandra Vasquez
  • Patent number: 10240129
    Abstract: The present invention relates to a novel bacteriophage ?CJ25 (KCCM11463P) and a composition comprising the same as an active ingredient. In addition, the present invention relates to a method for preventing and/or treating infectious diseases caused by avian pathogenic Escherichia coli (APEC) of birds by using the bacteriophage ?CJ25 (KCCM11463P) or the composition.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: March 26, 2019
    Assignee: CJ CHEILJEDANG CORPORATION
    Inventors: Eun Mi Shin, Gi Duk Bae, Jae Won Kim
  • Patent number: 10226064
    Abstract: Provided herein are bacterial strains that are capable of degrading nitrite and/or TSNAs. Also provided herein are methods of using such bacterial strains to degrade nitrite and/or TSNAs.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: March 12, 2019
    Assignee: Altria Client Services LLC
    Inventors: Ujwala Warek, Mark T. Nielsen, Dongmei Xu, Mingwu Cui, Xue Luo, Xiaohong Jin, Elisabeth Miller, Kwang Choi
  • Patent number: 10226489
    Abstract: The present invention provides a strain of Bacteroides thetaiotaomicron and derivatives thereof, and the use of said strain or derivatives in treating inflammatory, autoimmune and allergic disorders. The invention also provides pharmaceutical compositions, nutritional supplements, feedstuffs, food products, dietary supplements, and food additives comprising said strain or derivatives.
    Type: Grant
    Filed: June 23, 2017
    Date of Patent: March 12, 2019
    Assignee: 4D Pharma Research Limited
    Inventors: Angela Margaret Patterson, George Grant, Imke Mulder
  • Patent number: 10201574
    Abstract: Disclosed are methods of administering one or more Bacillus strains to poultry. The Bacillus strains improve bacterial homeostasis in the gastrointestinal tract by inhibiting bacterial pathogens such as E. coli and Clostridium. Administering the Bacillus strains also improves performance such as weight gain and feed conversion. Useful combinations of Bacillus strains and methods of using one or more Bacillus strains are also provided.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: February 12, 2019
    Assignee: Church & Dwight Co., Inc.
    Inventors: Thomas Rehberger, Evan Hutchison, Alexandra Smith, Joshua Rehberger
  • Patent number: 10188594
    Abstract: The present invention relates to a fermented vegetable oil, to a method for preparing the oil, and to a composition including the oil. More particularly, the present invention relates to a technique for providing a fermented vegetable oil having the effects of enhancing emulsion stability due to water retention ability, improving texture and flavor, and enhancing moisturization.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: January 29, 2019
    Assignees: DAMY CHEMICAL CO., LTD., KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
    Inventors: Kwang-Nyeon Kim, Ju-Hyun Son, Hee-Sik Kim, Jong-Seok Yun
  • Patent number: 10172892
    Abstract: Described are strains including Enterococcus faecium strain 8G-1 (NRRL B-50173), Enterococcus faecium strain 8G-73 (NRRL B-50172), Bacillus pumilus strain 8G-134 (NRRL B-50174) and strains having all of the identifying characteristics of each of these strains. One or more of the strains can be used to reduce negative energy balance in a ruminant. They can also be used to improve other measures of ruminant health and/or performance. Methods of using the strains, alone and in combination, are described. Methods of making the strains are also provided.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: January 8, 2019
    Assignee: DUPONT NUTRITION BIOSCIENCES APS
    Inventors: Elizabeth Galbraith, Keith Mertz, Ajay Awati
  • Patent number: 10166275
    Abstract: Provided herein is a antimicrobial sorption composition containing pyrogenic silica and serrathiopeptidase useful for the treatment of wounds such as festering wounds, necrotic wounds, exudative wounds, or wounds with inflammatory infiltration.
    Type: Grant
    Filed: August 20, 2017
    Date of Patent: January 1, 2019
    Assignee: Willingsford Limited.
    Inventors: Alexandr A. Golub, Olga Biliaieva, Viacheslav V. Neshta
  • Patent number: 10159701
    Abstract: A use of a Lactobacillus paracasei strain to prepare a composition for resisting bone loss is provided. The Lactobacillus paracasei strain GMNL-653 is capable of promoting the expression of TGF-? and IL-10, while inhibiting the expression of osteoclast related genes and reducing the content of IL-17A in serum, so that the bone loss is slowed down.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: December 25, 2018
    Assignee: GENMONT BIOTECH INC.
    Inventors: Yi-Hsing Chen, Wan-Hua Tsai, Chia-Hsuan Chou, Pei-Jane Tsai, Tsuei Yin Huang
  • Patent number: 10149872
    Abstract: Provided is the new strain Lactobacillus pentosus CECT 7504 and compositions and products comprising said strain and uses in the prevention and/or treatment of candidiasis (oral, intestinal and vaginal) and of bacterial vaginosis.
    Type: Grant
    Filed: August 11, 2014
    Date of Patent: December 11, 2018
    Assignee: Gynea Laboratorios, S.L.
    Inventors: Jordi Espadaler Mazo, Miguel Angel Losada Diaz
  • Patent number: 10143712
    Abstract: To provide a novel lactic acid bacterium strain having a broad antibacterial spectrum against bacteria that cause oral diseases, from which a fermented product having good flavor and being excellent in palatability can be produced, and a prophylactic, ameliorating or therapeutic agent for oral diseases using the same. A prophylactic, ameliorating or therapeutic agent for an oral disease, which contains a lactic acid bacterial cell of one or more kinds selected from the group consisting of Lactobacillus rhamnosus strain KO3, Lactobacillus casei strain YU3 and Lactobacillus paracasei strain YU4 or a culture of the cell, or an extract thereof, as an active ingredient.
    Type: Grant
    Filed: June 22, 2015
    Date of Patent: December 4, 2018
    Assignee: HIROSHIMA UNIVERSITY
    Inventor: Hiroki Nikawa